To include your compound in the COVID-19 Resource Center, submit it here.

PMX-30063: Phase I data

A double-blind, U.S. Phase I trial in 20 healthy volunteers showed that high-dose IV PMX-30063 was

Read the full 162 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE